Maternal and neonatal outcomes of births to women with psoriasis: a population-based cohort of 13 million births

References

• Rajguru JP, Maya D, Kumar D, et al. Update on psoriasis: a review. J Fam Med Prim Care. 2020;9(1):20–24.
   PubMedGoogle Scholar
• Vičić M, Kaštelan M, Brajac I, et al. Current concepts of psoriasis immunopathogenesis. Int J Mol Sci. 2021;22(21):11574.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960.
   PubMed Web of Science ®Google Scholar
• Dopytalska K, Ciechanowicz P, Wiszniewski K, et al. The role of epigenetic factors in psoriasis. Int J Mol Sci. 2021;22(17):9294.
   PubMed Web of Science ®Google Scholar
• Kaufman BP, Alexis AF. Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-white racial/ethnic groups. Am J Clin Dermatol. 2018;19(3):405–423.
   PubMed Web of Science ®Google Scholar
• Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–516.
   PubMed Web of Science ®Google Scholar
• Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.
   PubMed Web of Science ®Google Scholar
• Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5(3):141–150.
   PubMedGoogle Scholar
• Tauscher AE, Fleischer AB, Phelps KC, et al. Psoriasis and pregnancy. J Cutan Med Surg. 2002;6(6):561–570.
   PubMed Web of Science ®Google Scholar
• Bandoli G, Johnson DL, Jones KL, et al. Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. Br J Dermatol. 2010;163(2):334–339.
   PubMed Web of Science ®Google Scholar
• De Simone C, Caldarola G, Moretta G, et al. Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives. G Ital Dermatol Venereol. 2019;154(3):305–314.
   PubMed Web of Science ®Google Scholar
• Harder E, Andersen A-MN, Kamper-Jørgensen M, et al. No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis. J Invest Dermatol. 2014;134(6):1747–1749.
   PubMed Web of Science ®Google Scholar
• Polachek A, Polachek Shlomi I, Spitzer K, et al. Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls. Clin Rheumatol. 2019;38(3):895–902.
   PubMed Web of Science ®Google Scholar
• Remaeus K, Stephansson O, Johansson K, et al. Maternal and infant pregnancy outcomes in women with psoriatic arthritis: a swedish nationwide cohort study. BJOG. 2019;126(10):1213–1222.
   PubMed Web of Science ®Google Scholar
• Lima XT, Janakiraman V, Hughes MD, et al. The impact of psoriasis on pregnancy outcomes. J Invest Dermatol. 2012;132(1):85–91.
   PubMed Web of Science ®Google Scholar
• Yang YW, Chen CS, Chen YH, et al. Psoriasis and pregnancy outcomes: a nationwide population-based study. J Am Acad Dermatol. 2011;64(1):71–77.
   PubMed Web of Science ®Google Scholar
• Huang YH, Yee Ng C, Chiou MJ, et al. Fetal–neonatal and maternal outcomes in women with psoriasis vulgaris: a nationwide population‐based registry linkage study in Taiwan. J Dermatol. 2021;48(2):184–189.
   PubMed Web of Science ®Google Scholar
• HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Rockville (MD). 2020. [updated 2 Dec 2020]. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp#about.
   Google Scholar
• Peng C, Xu X, Chen W, et al. Epidemiological variations in the global burden of psoriasis, an analysis with trends from 1990 to 2017. Front Med (Lausanne). 2021;8:585634.
   PubMed Web of Science ®Google Scholar
• Icen M, Crowson CS, McEvoy MT, et al. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60(3):394–401.
   PubMed Web of Science ®Google Scholar
• Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–224.
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–1741.
   PubMed Web of Science ®Google Scholar
• Shiba M, Kato T, Izumi T, et al. Risk of myocardial infarction in patients with psoriasis: a cross-sectional patient-population study in a Japanese hospital. J Cardiol. 2019;73(4):276–279.
   PubMed Web of Science ®Google Scholar
• Horreau C, Pouplard C, Brenaut E, et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013;27:12–29.
   PubMed Web of Science ®Google Scholar
• Xiao J, Chen LH, Tu YT, et al. Prevalence of myocardial infarction in patients with psoriasis in Central China. J Eur Acad Dermatol Venereol. 2009;23(11):1311–1315.
   PubMed Web of Science ®Google Scholar
• Sajja AP, Joshi AA, Teague HL, et al. Potential immunological links between psoriasis and cardiovascular disease. Front Immunol. 2018;9:1234.
   PubMed Web of Science ®Google Scholar
• Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31(8):1000–1006.
   PubMed Web of Science ®Google Scholar
• Brauchli YB, Jick SS, Miret M, et al. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009;160(5):1048–1056.
   PubMed Web of Science ®Google Scholar
• Davidovici BB, Sattar N, Prinz J, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;130(7):1785–1796.
   PubMed Web of Science ®Google Scholar
• Cohen A, Dreiher J, Shapiro Y, et al. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venerol. 2008;22(5):585–589.
   PubMed Web of Science ®Google Scholar
• Cohen AD, Sherf M, Vidavsky L, et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology. 2008;216(2):152–155.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Fostini AC, Fossà I, et al. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36(1):21–28.
   PubMed Web of Science ®Google Scholar
• Mehta NN, Shin DB, Joshi AA, et al. Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo-controlled trial. Circ Cardiovasc Imaging. 2018;11(6):e007394.
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Shin DB, Alavi A, et al. A phase IV, randomized, double-blind, placebo-controlled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (the VIP-U trial). J Invest Dermatol. 2020;140(1):85–93.e2.
   PubMed Web of Science ®Google Scholar
• Ashlyn DL, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci. 2016;130(6):409–419.
   Web of Science ®Google Scholar
• Bröms G, Haerskjold A, Granath F, et al. Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden. Acta Derm Venereol. 2018;98(8):728–734.
   PubMed Web of Science ®Google Scholar
• Ben-David G, Sheiner E, Hallak M, et al. Pregnancy outcome in women with psoriasis. J Reprod Med. 2008;53(3):183–187.
   PubMed Web of Science ®Google Scholar
• Jankowska EA, Malyszko J, Ardehali H, et al. Iron status in patients with chronic heart failure. Eur Heart J. 2013;34(11):827–834.
   PubMed Web of Science ®Google Scholar
• Ponikowska M, Tupikowska M, Kasztura M, et al. Deranged iron status in psoriasis: the impact of low body mass. J Cachexia Sarcopenia Muscle. 2015;6(4):358–364.
   PubMed Web of Science ®Google Scholar
• Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017;356:j1.
   PubMed Web of Science ®Google Scholar
• Cohen-Barak E, Nachum Z, Rozenman D, et al. Pregnancy outcomes in women with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2011;25(9):1041–1047.
   PubMed Web of Science ®Google Scholar
• Bobotsis R, Gulliver WP, Monaghan K, et al. Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies. Br J Dermatol. 2016;175(3):464–472.
   PubMed Web of Science ®Google Scholar
• Vena GA, Cassano N, Bellia G, et al. Psoriasis in pregnancy: challenges and solutions. Psoriasis (Auckl). 2015;5:83–95.
   PubMedGoogle Scholar
• Babalola O, Strober BE. Management of psoriasis in pregnancy. Dermatol Ther. 2013;26(4):285–292.
   PubMed Web of Science ®Google Scholar
• Simionescu AA, Danciu BM, Stanescu AMA. State-of-the-art review of pregnancy-related psoriasis. Medicina (Kaunas). 2021;57(8):804.
   PubMed Web of Science ®Google Scholar
• Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62(6):385–392.
   PubMedGoogle Scholar
• Bay Bjørn AM, Ehrenstein V, Hundborg HH, et al. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther. 2014;21(2):73–80.
   PubMed Web of Science ®Google Scholar
• Skuladottir H, Wilcox AJ, Ma C, et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100(6):499–506.
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Feldman SR, Isaacs JD, et al. Pregnancy outcomes in the tofacitinib safety databases for rheumatoid arthritis and psoriasis. Drug Saf. 2016;39(8):755–762.
   PubMed Web of Science ®Google Scholar
• Hoffman MB, Farhangian M, Feldman SR. Psoriasis during pregnancy: characteristics and important management recommendations. Expert Rev Clin Immunol. 2015;11(6):709–720.
   PubMed Web of Science ®Google Scholar
• Bangsgaard N, Rørbye C, Skov L. Treating psoriasis during pregnancy: safety and efficacy of treatments. Am J Clin Dermatol. 2015;16(5):389–398.
   PubMed Web of Science ®Google Scholar
• Ferreira C, Azevedo A, Nogueira M, et al. Management of psoriasis in pregnancy - a review of the evidence to date. Drugs Context. 2020;9:2019-11-6.
   PubMedGoogle Scholar
• Auger N, Fraser WD, Healy-Profitós J, et al. Association between preeclampsia and congenital heart defects. JAMA. 2015;314(15):1588.
   PubMed Web of Science ®Google Scholar
• Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1–544.e12.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31(1):33–46.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Navare T, Gross J, et al. Clinical course of psoriasis during pregnancy. Int J Dermatol. 2003;42(7):518–520.
   PubMed Web of Science ®Google Scholar
• Lin X, Huang T. Impact of pregnancy and oestrogen on psoriasis and potential therapeutic use of selective oestrogen receptor modulators for psoriasis. J Eur Acad Dermatol Venereol. 2016;30(7):1085–1091.
   PubMed Web of Science ®Google Scholar
• Nograles KE, Davidovici B, Krueger JG. New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg. 2010;29(1):3–9.
   PubMed Web of Science ®Google Scholar
• Richard MA. Impact de la grossesse sur le psoriasis. Eur J Dermatol. 2020;30(S1):3–7.
   PubMedGoogle Scholar